The Food and Drug Administration reports provided more data but were more difficult to use than the European Medicines Agency reports
Open Access
- 1 January 2015
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 68 (1) , 102-107
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- US Food and Drug Administration documents can provide unpublished evidence relevant to systematic reviewsJournal of Clinical Epidemiology, 2013
- Strategies for obtaining unpublished drug trial data: a qualitative interview studySystematic Reviews, 2013
- Searching for unpublished data for Cochrane reviews: cross sectional studyBMJ, 2013
- Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analysesBMJ, 2011
- Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label UseNew England Journal of Medicine, 2009
- Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional AnalysisPLOS Medicine, 2009
- Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and PresentationPLOS Medicine, 2008
- Selective Publication of Antidepressant Trials and Its Influence on Apparent EfficacyNew England Journal of Medicine, 2008
- Empirical Evidence for Selective Reporting of Outcomes in Randomized TrialsJAMA, 2004
- How useful are unpublished data from the Food and Drug Administration in meta-analysis?Journal of Clinical Epidemiology, 2003